» Articles » PMID: 15944156

Yeast As a Tractable Genetic System for Functional Studies of the Insulin-degrading Enzyme

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Jun 10
PMID 15944156
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed yeast as an expression and genetic system for functional studies of the insulin-degrading enzyme (IDE), which cleaves and inactivates certain small peptide molecules, including insulin and the neurotoxic A beta peptide. We show that heterologously expressed rat IDE is enzymatically active, as judged by the ability of IDE-containing yeast extracts to cleave insulin in vitro. We also show that IDE can promote the in vivo production of the yeast a-factor mating pheromone, a function normally attributed to the yeast enzymes Axl1p and Ste23p. However, IDE cannot substitute for the function of Axl1p in promoting haploid axial budding and repressing haploid invasive growth, activities that require an uncharacterized activity of Axl1p. Particulate fractions enriched for Axl1p or Ste23p are incapable of cleaving insulin, suggesting that the functional conservation of these enzymes may not be bidirectionally conserved. We have made practical use of our genetic system to confirm that residues composing the extended zinc metalloprotease motif of M16A family enzymes are required for the enzymatic activity of IDE, Ste23p, and Axl1p. We have determined that IDE and Axl1p both require an intact C terminus for optimal activity. We expect that the tractable genetic system that we have developed will be useful for investigating the enzymatic and structure/function properties of IDE and possibly for the identification of novel IDE alleles having altered substrate specificity.

Citing Articles

Comprehensive analysis of CXXX sequence space reveals that Saccharomyces cerevisiae GGTase-I mainly relies on a2X substrate determinants.

Sarkar A, Hildebrandt E, Patel K, Mai E, Shah S, Kim J G3 (Bethesda). 2024; 14(8).

PMID: 38839053 PMC: 11304957. DOI: 10.1093/g3journal/jkae121.


Evaluating protein prenylation of human and viral CaaX sequences using a humanized yeast system.

Hildebrandt E, Sarkar A, Ravishankar R, Kim J, Schmidt W Dis Model Mech. 2024; 17(5).

PMID: 38818856 PMC: 11152559. DOI: 10.1242/dmm.050516.


Prenatal exposure to valproic acid reduces synaptic δ-catenin levels and disrupts ultrasonic vocalization in neonates.

Roh S, Mendez-Vazquez H, Sathler M, Doolittle M, Zaytseva A, Brown H Neuropharmacology. 2024; 253:109963.

PMID: 38657945 PMC: 11127754. DOI: 10.1016/j.neuropharm.2024.109963.


Comprehensive analysis of CXXX sequence space reveals that GGTase-I mainly relies on aX substrate determinants.

Sarkar A, Hildebrandt E, Patel K, Mai E, Shah S, Kim J bioRxiv. 2024; .

PMID: 38496651 PMC: 10942308. DOI: 10.1101/2024.03.04.583369.


A Humanized Yeast System for Evaluating the Protein Prenylation of a Wide Range of Human and Viral CaaX Sequences.

Hildebrandt E, Sarkar A, Ravishankar R, Kim J, Schmidt W bioRxiv. 2023; .

PMID: 37786692 PMC: 10541624. DOI: 10.1101/2023.09.19.558494.